The case for newborn screening for severe combined immunodeficiency and related disorders

Area of Science:

• Immunology
• Genetics
• Public Health

Background:

• Primary immunodeficiencies, particularly severe combined immunodeficiency (SCID), are life-threatening in infancy.
• Early diagnosis and intervention are critical to prevent severe infectious complications and improve outcomes.
• Current diagnostic approaches require timely identification of affected infants.

Purpose of the Study:

• To evaluate the integration of T cell receptor excision circles (TRECs) testing into newborn screening programs.
• To assess the feasibility of using TRECs as a biomarker for early SCID detection.
• To facilitate prompt intervention for infants identified with potential immunodeficiencies.

Main Methods:

• DNA analysis from dried blood spots collected during routine newborn screening.
• Measurement of T cell receptor excision circles (TRECs) as a biomarker for normal T cell development.
• Confirmatory testing and referral for infants identified as lacking TRECs.

Main Results:

• TREC testing was successfully integrated into newborn screening panels in five states.
• The method demonstrated timely detection of infants with SCID and other T lymphocytopenic conditions.
• Early results indicate the effectiveness of TRECs in identifying infants needing intervention.

Conclusions:

• TREC measurement is a viable addition to newborn screening for early detection of SCID.
• Successful integration into public health programs allows for prompt diagnosis and treatment.
• This approach significantly improves the chances of positive outcomes for affected infants.